The Liver Meeting 2023
Simple Exercise Could Benefit Patients With End-Stage Liver Disease
A prehabilitation program for liver transplantation can help improve frailty metrics in patients with end-stage ...
NOVEMBER 5, 2024

What Research Tells Us About Treating Alcohol-Associated Liver Disease
Alcohol-associated liver disease can be a tricky disease to treat. Researchers have increased their efforts to help ...
SEPTEMBER 27, 2024

Shortened Protocol Can Prevent Infection in Recipients of HCV+ Organs
A shortened antiviral protocol adding ezetimibe can prevent infection in solid-organ recipients who receive ...
JULY 31, 2024

Treatment Options for Pediatric Patients With MASLD
Endoscopic, surgical and pharmacologic therapies may be effective options for some children with MASLD, who are at ...
MAY 1, 2024

Transitioning Patients From Pediatric to Adult Hepatology Care Requires a Team Approach
MASH is a growing concern in the pediatric population, meaning more patients than ever are transitioning from ...
APRIL 9, 2024

Patients With ALD Have Lower Statin Uptake After Myocardial Infarction
Post–myocardial infarction patients are less likely to receive statins as part of their treatment if they ...
APRIL 2, 2024

Guidelines for Managing Children With GI Varices Often Not Followed
Pediatric guidelines recommend that children with gastrointestinal varices undergo endoscopic treatment, but not ...
FEBRUARY 29, 2024

Pilot Study Explores Screening of Newborns for Wilson’s Disease
Testing newborns for Wilson’s disease soon may be feasible and effective at a public health level.
FEBRUARY 27, 2024

How to Treat Liver Disease In the Midst of Health Disparities
Liver disease is on the rise in the United States, but not everyone has equal access to care.
FEBRUARY 26, 2024

Hepatology Consult May Help Patients With AUD Maintain Post-Treatment Sobriety
Patients who are being treated for alcohol use disorder may be more likely to maintain their sobriety if their ...
FEBRUARY 23, 2024

Aldafermin Shown to Reduce ELF Scores in Patients With MASH Cirrhosis
A trial evaluating aldafermin has found it effective and largely well tolerated in patients with compensated ...
FEBRUARY 20, 2024

Study Identifies Predictors of HRS-AKI
Researchers have identified certain characteristics that put patients with cirrhosis more at risk to develop ...
FEBRUARY 19, 2024
